Post-Covid anosmia/hyposmia is a troublesome persistent symptom for lots of patients. Management is still elusive. This was a nationwide survey of ENT practitioners. Of the 715 surveyed members, only 7.4% responded. Most performed a nasal endoscopy, 60% ordered an MRI and nearly no olfactory tests were ordered. At the therapeutic level, the most commonly used drugs were intranasal steroids and oral steroids, with home based olfactory training in 64% of cases. The main conclusion is that post-Covid olfactory dysfunction is poorly evaluated, rarely properly tested, and treatment is still suboptimal.